• No results found

The Akt/mTOR Pathwayand Estrogen Receptor Phosphorylations

N/A
N/A
Protected

Academic year: 2021

Share "The Akt/mTOR Pathwayand Estrogen Receptor Phosphorylations"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

The Akt/mTOR Pathway

and Estrogen Receptor Phosphorylations

– a crosstalk with potential to predict tamoxifen resistance

in breast cancer

JOSEFINE BOSTNER

Linköping University Medical Dissertations No. 1379

Linköping University Medical Dissertations No. 1379, 2013 Division of Medical Sciences

Department of Clinical and Experimental Medicine Faculty of Health Sciences

Linköping University 581 85 Linköping www.liu.se

Jos

efi

ne

B

os

tn

er

Th

e Ak

t/m

TO

R Pa

th

wa

y a

nd

E

str

oge

n R

ec

ep

tor

P

ho

sp

hor

yla

tio

ns

20

13

References

Related documents

whereas PAK1 gene amplification alone is a marker for reduced tamoxifen response. Paper II High nuclear Pak1 protein expression and phosphorylated ER at serine 305, together

Vid en första anblick kan naturligtvis frågan vad S:t Barthelemy, en lag om införsel av vapen och ammunition till Afrika, svenska upptäcktsfärder och förhållandet till

In Study II clamping of the in- dwelling urinary catheter before removal was not shown to be of any ad- vantage in patients with hip fractures, regarding either time to normal

Anledningen till att halten är kraftigt förhöjd för två ämnen i de danska vilda musslorna samt för ett ämne i de svenska vilda musslorna är okänd, dock kan det finnas en

Despite the dissimilarities to in vivo condition, the in vitro the scratch assay showed an initial wound healing reaction that was characterized by a cell migration to close the

Yuliya Lakew (2020): Matters of Public Connection: The role of mediated and interpersonal communication in young people’s environmental engagement.. Örebro Studies in Media

Chewing gum and human hair as retrospective dosimeters Axel Israelsson.. Linköping University Medical

v-AKT murine thymoma viral oncogene homologue (AKT), amyloid precursor protein (APP), breast cancer specific survival (BCS), cyclophosphamide-methotrexate-5-fluorouracil (CMF),